# Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants

> **NCT01576003** · NA · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 10 (actual)

## Conditions studied

- Bloodstream Infections
- Short Bowel Syndrome
- Development
- Nutrition
- Biological Markers

## Interventions

- **DRUG:** Glutamine
- **DIETARY_SUPPLEMENT:** L-alanine

## Key facts

- **NCT ID:** NCT01576003
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-06-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01576003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01576003, "Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01576003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*